Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
036
|
Date of Entry 07/09/2014
|
FR Recognition Number
|
7-48
|
Standard | |
CLSI C60-A Blood Alcohol Testing in the Clinical Laboratory; Approved Guideline |
|
Scope/AbstractThe cost of alcohol abuse in our society is extraordinarily high in terms of the loss of human life, its detrimental contribution to the causes of illness and injury, productivity losses in the workplace, and the stress these in turn put on our medical resources and our judicial system. In a series of special workshops on alcoholism and alcohol abuse, the American Society of Clinical Pathologists Task Force on Drug Abuse and Toxicology1 recognized the magnitude of the problem of alcohol in our society. The title of these seminars was "Alcohol - The Second Great Imitator" because of the medical challenges in the diagnosis of this problem. |
|
Extent of Recognition
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§862.1145 |
Cresolphthalein Complexone, Calcium
|
Class 2
|
CIC
|
§862.3040 |
Potassium Dichromate Specific Reagent For Alcohol
|
Class 2
|
DMI
|
§862.3040 |
Enzymatic Method, Alcohol Dehydrogenase, Ultraviolet
|
Class 2
|
DMT
|
§862.3040 |
Potassium Dichromate, Alcohol
|
Class 2
|
DOJ
|
|
Relevant FDA Guidance and/or Supportive Publications*
Points to Consider for Consider for Collection of Data in Support of In-Vitro Device Submissions for 510(k) Clearance, Issued September 1994.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |